Trevor Fedor News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Trevor fedor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Trevor Fedor Today - Breaking & Trending Today
Do with the manufacturing reports. But not much movement. Olivia a big earnings day with 30 S P Companies reporting today. Earnings numbers are coming in pretty mixed. A little more action in the currency market that is pretty much flat also. , the dollarndex dropping from a fourmonth high and the euro a little stronger but under 1. 10. Perhaps the real story is the the royal bank of australia left benchmark Interest Rates unchanged. Little movement on oil prices, perhaps a rebound from yesterdays selloff, but a commodity driven currency like the aussie dollar and canadian kurt the taking a hit in recent months. More Health Care Companies are making deals. Today, one is excepted while a much larger one is being turned down. Team Health Holdings agreed to abou ....
The chart. One stock that has dragged the dow down is apple. It is up 4 in the past six months, as you can see. A lot of red these days are commodities. In particular the oil market. We are seeing a nice rebound, particularly nine next crude up almost 2 at 46. 05. Read crude is rebounding after the significant top low 50 a barrel. Pimm and that move in the oil markets copy commodity related markets like the aussie dollar. On the bond market and see how treasuries are faring. A little bit of the selloff and the 10 year yield goes to 18, the 30 year moves higher to 288. A little bit of selling in the bond market. Speaking of bonds, lets look at s and p municipal up and you can thetaking a big guys since beginning of the spring, down the index of, puerto rico bonds as the commonwealth attempts to restructure its more than 75 billion worth of debt. We will be speaking with puerto ricos house of representatives, Pedro Peirluisi talkin ....
Continues. Bayer will buy america consumer over the counter business for 14. 2 billion. Also the two companies are establishing a have a teemgic collaboration in cardiovascular diseases. And this will vowill involve me paying 2 billion to bayer. But again, the big headline here is the 14. 2 billion deal for mercks over the counter consumer business. Why is there so much deal making going on in pharmaceuticals . This has been incredible. Weve seen a swap from glaxo and novartis. This is a way for companies to hone in on what theyre good at. Were hearing a lot of pharmaceutical companies saying they need scale, they need to cut costs and they want to be number one or two in positions where theyre playing. So areas where theyre a little bit smaller, were seeing these asset swaps. And now of course this is all set against the backdrop of pfizer making its 106 billion bid for astrazeneca which is eclipsing Everything Else going on in ....